The online version of this article (doi:10.1186/1471-2296-15-96) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
FF reviewed needs assessment data and final report and wrote the manuscript. KF led IRB submission and completed statistical analysis of quantitative data. AH participated in writing the application for the original project grant, participated in data analysis, wrote the final report, and finalized the manuscript. TM led methodology design, survey design, and data collection/analysis. PM served as Principal Investigator for the project. All authors read and approved the final manuscript.
While overactive bladder is often managed in the primary care setting, a number of barriers including embarrassment, poor communication, and low patient adherence contribute to the under-treatment of patients with burdensome urinary symptoms. In order to address these challenges, it is crucial to have a fundamental understanding of patient perspectives toward OAB and urinary symptoms. To meet this aim, researchers designed and conducted a study to identify patients’ knowledge, experiences and attitudes, barriers to treatment adherence, and desires and tendencies regarding patient/clinician communications.
A mixed-methods qualitative/quantitative needs assessment of patients with overactive bladder and/or urinary symptoms. Researchers conducted in-depth qualitative interviews via telephone with 40 patients. Interview results informed the design and dissemination of a quantitative survey, which was completed by 200 self-selected respondents who had previously identified themselves as having overactive bladder or bladder problems. Statistical and qualitative analysis of results were conducted.
Among survey respondents, an average of 3.5 years elapsed between symptom onset and seeking diagnosis by a physician. In the long term most patients do not experience improvement in symptoms. Medication non-adherence is common and is related to therapy effectiveness and adverse effects. Patients clearly indicate that communication and patient/physician relationships are important to them and they would prefer the clinician initiate the conversation on overactive bladder. Patient experiences, perspectives, and attitudes toward their bladder symptoms differ in many ways from clinicians’ assumptions.
The significant time gap between symptom onset and diagnosis indicates ongoing need for screening and diagnosis of overactive bladder. Contrary to guideline recommendations, urinalysis and physical examination are not widely used in clinical practice. Many patients experience no improvement in symptoms over time. Patients indicate that clinician/patient relationships and communication regarding their condition are important.
Haylen BT, Ridder de D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN: International Urogynecological Association; International Continence Society: an International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010, 29: 4-20. PubMed
Sexton CC, Coyne KS, Thompson C, Bavendam T, Chen CI, Markland A: Prevalence and effect on health-related quality of life of overactive bladder in older Americans: results from the epidemiology of lower urinary tract symptoms study. J Am Geriatr Soc. 2011, 59: 1465-1470. 10.1111/j.1532-5415.2011.03492.x. CrossRefPubMed
Sand PK, Goldberg RP, Dmochowski RR, McIlwain M, Dahl NV: The impact of the overactive bladder syndrome on sexual function: a preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial. Am J Obstet Gynecol. 2006, 195: 1730-1735. 10.1016/j.ajog.2006.08.013. CrossRefPubMed
Abrams P, Kelleher CJ, Kerr LA, Rogers RG: Overactive bladder significantly affects quality of life. Am J Manag Care. 2000, 6 (Suppl 11): S580-S590. PubMed
Rosenberg M, Miner M, Greenberg D, Laroche C: Keep it simple, effective, and safe. Can J Urol. 2008, 15 (Suppl 1): 2- PubMed
Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster Jr HE, Scarpero HM, Tessier CD, Vasavada SP: American Urological Association; Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction: diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012, 188 (Suppl 6): 2455-2463. CrossRefPubMed
Borello-France D, Burgio KL, Goode PS, Markland AD, Kenton K, Balasubramanyam A, Stoddard AM: Adherence to behavioral interventions for urge incontinence when combined with drug therapy: adherence rates, barriers, and predictors. Phys Ther. 2010, 90: 1493-1505. 10.2522/ptj.20080387. CrossRefPubMedPubMedCentral
- The patient perspective on overactive bladder: a mixed-methods needs assessment
Frank A Filipetto
Kimberly G Fulda
Amy E Holthusen
Thomas M McKeithen
- BioMed Central
Neu im Fachgebiet Allgemeinmedizin
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II